Insider Transactions in Q3 2025 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 08
2025
|
Mark W Hahn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,320
-0.72%
|
$993,520
$11.44 P/Share
|
|
Jul 08
2025
|
David Zaccardelli President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
90,320
-0.67%
|
$993,520
$11.44 P/Share
|
|
Jul 08
2025
|
Andrew Fisher General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
39,464
-8.85%
|
$434,104
$11.44 P/Share
|
|
Jul 08
2025
|
Kathleen A. Rickard Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,616
-1.43%
|
$413,776
$11.44 P/Share
|
|
Jul 07
2025
|
Mark W Hahn Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
229,512
+1.8%
|
-
|
|
Jul 07
2025
|
David Zaccardelli President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
229,512
+1.68%
|
-
|
|
Jul 07
2025
|
Andrew Fisher General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
86,064
+16.17%
|
-
|
|
Jul 07
2025
|
Kathleen A. Rickard Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
86,064
+3.17%
|
-
|